International Clinical Trial: Specimen and Data Collection for a Novel Biomarker Combination for the Differential Diagnosis of Inflammatory Bowel Disease and Irritable Bowel Syndrome

Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07471490) titled 'Specimen and Data Collection for a Novel Biomarker Combination for the Differential Diagnosis of Inflammatory Bowel Disease and Irritable Bowel Syndrome' on March 10.

Study Type: Observational [Patient Registry]

Primary Sponsor: DiaSorin Inc.

Condition: IBD (Inflammatory Bowel Disease) IBS (Irritable Bowel Syndrome) Gastrointestinal Symptoms

Recruitment Status: Recruiting

Date of First Enrollment: May 7, 2025

Target Sample Size: 300

Countries of Recruitment: United States Italy United States

To know more, visit https://clinicaltrials.gov/study/NCT07471490

Published by HT Digital Content Services with perm...